Overview

Effects of Psilocybin in Post-Treatment Lyme Disease

Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study will examine the effects of psilocybin on Lyme disease symptom burden and quality of life in people with Post-Treatment Lyme Disease (PTLD).
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Steven and Alexandra Cohen Foundation
Treatments:
Psilocybin